These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4253913)

  • 1. [So-called essential renal hematuria and fibrinolytic enzyme system].
    Manabe H
    Hinyokika Kiyo; 1971 May; 17(5):314-29. PubMed ID: 4253913
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on unexplained renal hematuria. 1. Clinical studies of peripheral blood examination and fibrinolytic enzyme systems in patients with various types of renal hematuria (author's transl)].
    Hayashi M
    Nihon Hinyokika Gakkai Zasshi; 1981 Jan; 72(1):42-59. PubMed ID: 7024604
    [No Abstract]   [Full Text] [Related]  

  • 3. [The relationship between exercise and the fibrinolytic enzyme system. 1. The relationship between the fibrinolytic enzyme system in the blood and microhematuria due to exercise].
    Kono N; Maatsuzaki S
    Nihon Hinyokika Gakkai Zasshi; 1968 Oct; 59(10):877-93. PubMed ID: 4237220
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of physical exertion on the fibrinolytic enzyme system in uremic and non-uremic patients with kidney patients].
    Rosdy E; Goldschmidt B
    Acta Chir Acad Sci Hung; 1970; 11(4):283-7. PubMed ID: 4252879
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrinolytic activity of proactivator and activator in human urine.
    Kamada T
    Nihon Hoigaku Zasshi; 1967 Nov; 21(6):541-51. PubMed ID: 4233846
    [No Abstract]   [Full Text] [Related]  

  • 6. A new method based on one dimensional diffusion using small glass tubes for the measurement of fibrinolytic activity. I. Fibrinolytic activity of plasmin and "euglobulin + streptokinase".
    Yasukouchi T; Watanabe T
    Thromb Diath Haemorrh; 1972 Dec; 28(3):329-41. PubMed ID: 4265315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enzymatic and nonenzymatic fibrinolysis in various kidney diseases].
    Sokratov NV
    Ter Arkh; 1983; 55(6):55-8. PubMed ID: 6193598
    [No Abstract]   [Full Text] [Related]  

  • 8. [Endogenous and exogenous fibrinolysis (with reference to the fibrinolytic activity of the kidney and blood cell constituents)].
    Abe T; Kazama M
    Saishin Igaku; 1966 Feb; 21(2):260-73. PubMed ID: 4226029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fibrinolytic system of blood in patients with hypertensive disease].
    Fatkhullaev IF; Agapova LA
    Ter Arkh; 1974; 46(6):24-7. PubMed ID: 4279461
    [No Abstract]   [Full Text] [Related]  

  • 10. [Change in fibrinogen and enzymatic and nonenzymatic fibrinolytic activity of blood in patients with low-degree rheumatic heart disease under the effect of treatment with acetylsalicylic acid].
    Andreenko GV; Samsonov MA; Paramonova EG; Karabasova MA; Redziuk LA
    Ter Arkh; 1976; 48(11):64-70. PubMed ID: 139704
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolytic system in patients with hypertensive cardiovascular disease.
    Prokopowicz J; Worowski K; Poplawski A; Gabryelewicz A; Niewiarowski S
    Thromb Diath Haemorrh; 1967 Feb; 17(1-2):1-7. PubMed ID: 4230957
    [No Abstract]   [Full Text] [Related]  

  • 12. [The fibrinolytic activity of human tissues].
    Perlewitz J; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):46-50. PubMed ID: 4189371
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinolytic activity in renal disease.
    Ito T; Niwa T; Matsui E
    Clin Chim Acta; 1972 Jan; 36(1):145-51. PubMed ID: 4257416
    [No Abstract]   [Full Text] [Related]  

  • 14. Arterio-venous differences in the components of the fibrinolytic enzyme system.
    Ogston D; Ogston CM; Bennett NB
    Thromb Diath Haemorrh; 1966 Jul; 16(1):32-7. PubMed ID: 4229628
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical pharmacology of the fibrinolysin system of the rat. I. The effect of alloxan-induced hyperglycemia.
    Lassman HB; Wilkens HJ; Back N
    J Pharmacol Exp Ther; 1974 May; 189(2):317-26. PubMed ID: 4275231
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K; Prokopowicz J; Gabryelewicz A
    Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fibrinolysis in general anesthesia. 1. Changes in the plasmin level in clinical cases].
    Endo M; Aoki M; Iiizumi K; Takayasu J; Nasu T
    Masui; 1968 Jun; 17(6):512-21. PubMed ID: 4235586
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of ischemia of the brain and transplanted kidney on fibrinolytic activity.
    Baciu I; Oprisiu C; Dorofteiu M; Suciu A; Kowarzyk H; Kotschy M
    Arch Immunol Ther Exp (Warsz); 1970; 18(2):195-200. PubMed ID: 4911951
    [No Abstract]   [Full Text] [Related]  

  • 19. [Measurement of the fibrinolytic activation capacity of urine. Description of a simplified method. Role of ions].
    Kahn JP; Verbanck M
    Pathol Biol (Paris); 1973 Apr; 21(4):339-47. PubMed ID: 4576171
    [No Abstract]   [Full Text] [Related]  

  • 20. The activator time. A method for control of activator activity during thrombolytic therapy.
    Blix S
    Scand J Haematol; 1969; 6(4):221-6. PubMed ID: 5388562
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.